In summary, by using pharmacological and genetic approaches, we demonstrated that HO-1 plays a protumor role and that both the enzymatic activity and the subcellular location of HO-1 determine its participation in HNSCC malignancy. Here, HMOX1 is linked to head and neck squamous cell carcinoma.